Items where authors include "Hurwitz, H"

Article

Burzykowski, T, Coart, E, Saad, ED et al. (24 more authors) (2019) Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. JAMA Network Open, 2 (9). e1911750.

Seligmann, JF, Hatch, AJ, Richman, SD orcid.org/0000-0003-3993-5041 et al. (8 more authors) (2018) Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer. JAMA Oncology, 4 (4). pp. 564-568. ISSN 2374-2437

Sjoquist, KM, Renfro, LA, Simes, RJ et al. (31 more authors) (2017) Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. Journal of the National Cancer Institute, 10 (6). djx253. ISSN 0027-8874

Renfro, LA, Goldberg, RM, Grothey A et al. (24 more authors) (2017) Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. Journal of Clinical Oncology, 35 (17). pp. 1929-1937. ISSN 0732-183X

Sommeijer, DW, Shi, Q, Meyer, J et al. (17 more authors) (2013) Prognostic value of Early Objective Tumor Resonse (EOTR) to first line systemic therapy in Metastatic Colorectal Cancer (MCRC): Individual Patient Data (IPD) meta-analysis of randomized trials from the ARCAD database. Asia-Pacific Journal of Clinical Oncology, 9 (S3). 76 - 76. ISSN 1743-7555

Proceedings Paper

Seligmann, JF, Elliott, F, Jacobs, B et al. (10 more authors) (2015) HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC). In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL. American Society of Clinical Oncology .